Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q1 Loss
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $48.67 --0%
Revenue Growth %: +15.2%
Financial Fact:
Interest income: 110K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.2%
Financial Fact:
Interest income: 110K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi turns more bullish on trucking stocks
- Guggenheim Reiterates Buy Rating on Oracle (ORCL)
- GE Aerospace to buy CPP for $11.75 billion in castings deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
